LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company Read more about LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company
Laboratory Corporation of America® Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance Read more about Laboratory Corporation of America® Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance
LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients Read more about LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients
LabCorp’s Acquisition of LipoScience Clears Antitrust Approval Read more about LabCorp’s Acquisition of LipoScience Clears Antitrust Approval
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Announces Agreement to Acquire LipoScience Read more about LabCorp Announces Agreement to Acquire LipoScience
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
LabCorp’s Enlighten Health Launches Innovative Genomics Initiative Read more about LabCorp’s Enlighten Health Launches Innovative Genomics Initiative
LabCorp Announces the Availability of InformaSeqSM Non-Invasive Prenatal Test Read more about LabCorp Announces the Availability of InformaSeqSM Non-Invasive Prenatal Test
Laboratory Corporation of America® Holdings Announces 2014 Second Quarter Results and Increases 2014 EPS Guidance Read more about Laboratory Corporation of America® Holdings Announces 2014 Second Quarter Results and Increases 2014 EPS Guidance
